The American Society of Clinical Oncology (ASCO) Annual Meeting is a pivotal event that brings together experts in the field of oncology to share groundbreaking research and advancements in cancer care. ASCO 2024 continued to push the boundaries of scientific discovery, with an emphasis on precision medicine, immunotherapy, and emerging technologies
ONCOLOGY
"Science is not only a disciple of reason but also one of romance and passion" Stephen HawkingsDarkDrug Articles on the Topic of
ONCOLOGY
ASCO 2024: Unleashing the Power of Precision Oncology and Immuno-Therapeutics
The American Society of Clinical Oncology (ASCO) Annual Meeting is a pivotal event that brings together experts in the field of oncology to share groundbreaking research and advancements in cancer care. ASCO 2024 continued to push the boundaries of scientific discovery, with an emphasis on precision medicine, immunotherapy, and emerging technologies
The Promise of CAR T-Cells: Progress and Challenges in Cancer Immunotherapy
Over a decade since the first clinical trials began, long-term follow-up data have affirmed CAR T-cells’ ability to induce durable remissions in certain patients. However, the therapy also faces challenges, as not all treated cancers respond equally well and toxicity remains a concern. Ongoing research aims to optimize various aspects of CAR T-cell treatment to improve outcomes on a broader scale.
Predicting Cancer Risk with Digital Health Records
Every day we leave traces of our lives in digital systems. While privacy concerns abound, this digitization of daily life also presents new opportunities for medical research. Scientists are now tapping into nationwide databases of electronic health records to gain insights that were previously impossible
Unlocking Precision Cancer Care through Whole Genome Sequencing
Tumors can vary greatly between patients and even within the same patient over time as the disease progresses. To improve patient outcomes, oncologists need a more comprehensive understanding of the molecular changes driving each individual's cancer
Antibodies Revolutionizing Cancer Care: Past Successes and Future Promise
Antibody-based therapies have transformed cancer treatment over the past few decades. A recent review published in Nature Reviews Cancer provides a comprehensive overview of the progress made to date and the exciting new frontiers on the horizon
AI | Personalizing Cancer Care with Artificial Intelligence
AI is now enabling truly personalized care, however, realizing this promise will require overcoming major regulatory hurdles to get these novel technologies safely into clinical practice
Preventing Unnecessary Chemotherapy after Surgery for Early Breast Cancer
More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE
Unraveling the Mechanisms Behind Resistance to Novel Cancer Therapies
Scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers
- New discovery aims to improve the design of...on September, 2024 at 2:52 pm
A new study is providing new insights into how next-generation electronics, including memory components in computers, breakdown or degrade over time.
- Unveiling the math behind your calendaron September, 2024 at 2:52 pm
In a world where organizing a simple meeting can feel like herding cats, new research reveals just how challenging finding a suitable meeting time becomes as the number of participants grows. The study dives into the mathematical complexities of this common task, offering new insights into why […]
- Breakthrough in proton barrier films using...on September, 2024 at 4:33 am
Scientists have announced a groundbreaking development in hydrogen ion barrier films using graphene oxide (GO) that lacks internal pores. This innovative approach promises significant advancements in protective coatings for various applications.
- Enzyme-inspired catalyst puts chemicals in right...on September, 2024 at 8:17 pm
Taking inspiration from enzymes, chemists have developed a catalyst to simplify the synthesis of ethers, key functional components of many drugs, foods, personal care items and other consumer goods. The catalyst puts the two chemical ingredients in just the right proximity and position to come […]
- Discovery could lead to longer-lasting EV...on September, 2024 at 6:24 pm
Researchers have discovered why lithium-ion batteries, which power most electronic devices, lose capacity overtime. The findings could enable the development of electric vehicles that go far longer without needing a charge.
After 11 years, Boston Dynamics has said goodbye to its humanoid robot ATLAS HD. The robotics company says it’s time for ATLAS to “kick back and relax” in retirement, letting the new all electric ATLAS take over. This video was shared to remember ATLAS HD’s great moments and those not so great.
Header Banner: Speed is the name of the game. The DarkDrug logo shows an Intel Xeon microchip die. Xeon is a brand of x86 microprocessors designed, manufactured, and marketed by Intel, targeted at the non-consumer workstation, server, and embedded system markets. It was introduced in June 1998. The advent ofoptical fibre cable has allowed the speed of data transmission to reach dizzy heights (shown in the DarkDrug logo). The field of applied science and engineering concerned with the design and application of optical fibers is known as fibre optics. The term was coined by Indian physicist Narinder Singh Kapany, who is widely acknowledged as the father of fibre optics.